Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
about
Cannabis Smoking in 2015: A Concern for Lung Health?Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for drivingBiological markers of drug use in the club setting.Predicting drug use at electronic music dance events: self-reports and biological measurementTunable detection sensitivity of opiates in urine via a label-free porous silicon competitive inhibition immunosensor.Drug testing in oral fluid.Oral fluid testing for drugs of abuse.Current knowledge on cannabinoids in oral fluid.A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluidOral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.Bioanalytical procedures for monitoring in utero drug exposure.Bioanalytical methods for the determination of cocaine and metabolites in human biological samples.Current technologies and considerations for drug bioanalysis in oral fluid.Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges.Bioanalytical procedures and recent developments in the determination of opiates/opioids in human biological samples.Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods.Chemiluminescence microarrays in analytical chemistry: a critical review.Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in Driving Under the Influence of Drugs.Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.Urine and oral fluid drug testing in support of pain management.Comparison of drug concentrations between whole blood and oral fluid.Rapid detection and quantitation of ketamine and norketamine in urine and oral fluid by wooden-tip electrospray ionization mass spectrometry.Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden.Roadside drug testing: An evaluation of the Alere DDS® 2 mobile test system.Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.Comparison of Cocaine/Crack Biomarkers Concentrations in Oral Fluid, Urine and Plasma Simultaneously Collected From Drug Users.Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).Driving under the influence of amphetamine-like drugs.Analysis of drugs of abuse in Cerumen - correlation of postmortem analysis results with those for blood, urine and hair.[Substance abuse detection in substitution therapy : Oral fluid versus urine screening].Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.Comparison of the Cozart DDS 801 on-site drug test device and gas chromatography/mass spectrometry (GC/MS) confirmation results of cannabis and cocaine in oral fluid specimensAn overview of quantifying and screening drugs of abuse in biological samples: Past and presentDetermination of Illicit Drugs in Urine and Plasma by Micro-SPE Followed by HPLC–MS/MS
P2860
Q26850819-EAB76142-B6E9-41E3-A00C-CA60F9E1C54BQ28484782-E62B3433-CD16-4595-A1D8-E65105AB801BQ30375343-2C8B4A5A-EFDE-4D1E-B27C-478C068660A1Q30376026-2410578E-1A2E-4002-8C72-186AD0A7471EQ33622530-496E42FD-21D8-47DE-8DDC-D3AF5E2E805EQ35053485-C67439B4-F123-49D7-BA38-35300C6637A5Q35190524-3B24E5A9-5965-4213-B2B9-AA0B4D534D4DQ35940339-01717DB7-DE73-4E8A-9B2D-55E21EC0BA10Q36275417-1FD0E23D-2E45-4033-B12B-D24F64845992Q36600912-5A64BA92-8034-45C7-935F-57613B3A55B3Q36763641-18A74335-B87E-4B3D-A09C-C29FD9378DEEQ37810146-3671DE9B-DFC2-4FBC-8A8E-AF589A67DB78Q37810195-FA28F6F1-2B2A-4406-B473-79231E3DCD5CQ37810239-386F7092-E95F-4E27-90A2-A5AC97862A04Q37858459-4B3CDE20-4E23-4F06-9104-A18D63865264Q37943704-D984C7AE-B747-4BF8-90EE-E949FD8A951EQ38227132-F4B524E6-1B86-4248-A3F6-C3D4F9E08C8EQ38605437-D92380F1-0809-45BD-B114-3791212C05CEQ39906616-21ACE8C7-0963-458D-8F98-96ED0996CB1BQ40984910-A5DED84C-C5AC-4178-A895-46C40A41E205Q41962768-AFE883CC-B393-4E71-97AC-1392095DF2E2Q41989786-435DA36D-0E42-4A16-B980-6AF955EBA77EQ43463638-45E562A2-48F0-4623-B4B6-A5A37D38EB84Q43682075-5627D9E3-C00D-468A-B4D1-131F27C36C15Q44982667-3659AE38-D229-4BA5-AA95-DF5BAC197D41Q46259058-FE97A4A1-D98E-49BA-A557-7155157C7D2AQ47315816-57D4D55D-36EB-4208-A8AC-0012BCFC7C06Q47593473-20C9AD1C-2C23-4BA1-BF65-895181101535Q47611938-3302BBE7-2BC2-4F7C-B94D-8F77AB66A142Q48167533-01A5504F-9D82-4B97-A342-4450599E8853Q48187063-4EEC6C49-4717-4608-9EA2-49A2D90AA1B7Q48191570-A317A644-35CB-4377-84B6-54992F0185FBQ50002826-323199F8-6840-44FC-A40F-1CBA65C7A81CQ50586416-E0C219A1-786B-48A1-BBFD-F0E9613B5674Q51324610-CFA79908-7A1B-4791-A1E4-0CB241EDD0F7Q54645752-7CCB372E-67C9-43E3-A125-DD8955400518Q57571876-69DB3B22-E679-4A44-AE93-2AA220079937Q57756369-35663EFF-4320-4E07-AC7C-C84ABC974A29Q58831904-B873226F-6078-4336-83B6-01FC672AD5E6
P2860
Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Driving under the influence of ...... tion with impairment symptoms.
@ast
Driving under the influence of ...... tion with impairment symptoms.
@en
type
label
Driving under the influence of ...... tion with impairment symptoms.
@ast
Driving under the influence of ...... tion with impairment symptoms.
@en
prefLabel
Driving under the influence of ...... tion with impairment symptoms.
@ast
Driving under the influence of ...... tion with impairment symptoms.
@en
P2093
P1476
Driving under the influence of ...... tion with impairment symptoms.
@en
P2093
Gerold F Kauert
Manfred R Moeller
Stefan Steinmeyer
Stefan W Toennes
P304
P356
10.1016/J.FORSCIINT.2004.08.002
P577
2005-09-01T00:00:00Z